Categories: Standardized Reading Procedures

Oncologic imaging: lung cancer screening in mint Lesion

Lung Cancer Screening in Germany – A Turning Point for Early Detection

Few topics are currently as impactful in radiology as lung cancer screening. From 2026, Germany is expected to roll out a nationwide program, marking…

ESOI-EORTC Workshop: Hands-On Training in Assessing Tumor Response to Treatment

The ESOI-EORTC workshop, hosted by the European Society of Oncological Imaging (ESOI) and the European Organization for Research and Treatment of…

Systems on FHIR: Driving Healthcare Innovation Through Interoperability

Interoperability is revolutionizing healthcare by enabling the seamless exchange of patient data across systems. This efficient data flow is critical…

mint Lesion screenshot with PET evaluation, SUV, customized response criteria

Customizable reading templates for therapy response assessment

mint Lesion offers customizable reading templates for therapy response assessment in clinical care and research. Adapt parameters, define lesion…

Interdisciplinarity in healthcare

Insights into the BZKF BORN-Project – Interview with Dr. Mandy Wahlbuhl-Becker

The Bavarian Oncological Radiology Network (BORN) is enhancing cancer diagnostics in Bavaria through standardized imaging and structured reporting.  …

AI lung nodules detection in contextflow and Lung-RADS in mint Lesion

Leverage Advanced AI-Driven Nodule Detection and Analysis for Comprehensive Patient Care

Discover the power of streamlined AI-driven lung screening with contextflow ADVANCE Chest CT integrated into mint Lesion. With automated lung nodule…

Hands holding a glass lung

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing…

Image shows graphic related to study's research on iRECIST and RECIST

University Hospital Cologne: Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

A retrospective study conducted at University Hospital Cologne compared two criteria for assessing therapeutic response to immunotherapy: iRECIST and…

Doctors holding up puzzle pieces

Developing Standardized Reporting Templates for Sarcomas: Insights from Prof. Dr. Wolfgang Kunz

Sarcomas are a rare and heterogeneous group of malignant tumors that pose significant challenges in both diagnosis and treatment. Within the framework…